Description: Most insurers operate in a multi-GAAP world: Many U.S. insurers are regulated on a statutory/risk-basec capital (RBC) basis, report to markets under U.S. GAAP, pay taxes on a tax basis of accounting, and manage their business internally on an economic or other basis. In addition, many have overseas entities exposed to even more reporting bases. Reporting requirements are ever increasing and convergence of frameworks is not a reality in most parts of the world.Learn about a multi-GAAP framework to gain a bottom-up understanding of the differences in reserves and other balance sheet and income statement line items across reporting bases, both now and for future projections/plans. Using such an approach enhances insight into the valuation of the business, removes inconsistencies and results in operational efficiencies in the valuation process. At the conclusion of the session, you will learn technical concepts behind the Multi-GAAP framework and some practical ways to design and implement it.

Description: Under U.S. GAAP long-duration targeted improvements (LDTI), some non-VA annuity products contain features scoped in as 'market risk benefits' (MRBs), which are required to be measured at fair value. For U.S. insurers, the question becomes 'How does the emerging principle-based reserving framework for non-variable annuities compare to the fair value framework for MRBs under LDTI?' See a comparison between these two new measurement models, highlighting some of the key considerations due to the added complexity of these calculations, to help companies strategically plan for their future state.

Description: After the arduous journeys IFRS 17 filers underwent to implement the standard, it would only make sense for insurers to seek the best return on their investment post effective date of 1/1/2023. Many insurers are now embarking a new phase of the journey that involves wrapping up any unfinished business as they might have taken a minimum compliance route to finish implementation and thinking about the knock-on effects the new standard has on the way they carry out business and perform financial reporting.

Description: While a rising sea helps all ships, the insurance industry is a ship that hasn't seen much water in the past decade. Examine valuation and product management considerations in a high interest rate environment

Description: This report provides a framework that actuaries can use to evaluate moderately adverse conditions.

Description: The Valuation Actuary (ValAct) Meetings empower actuaries across all practice areas for success with in-depth content on the latest valuation and financial reporting concepts. ValAct content is tailored for professionals specializing in valuation actuarial practices within the insurance and financial industries.

Description: The Society of Actuaries will host two great events for the valuation actuarial community. Get empowered for success with in-depth content on the latest valuation and financial reporting concepts, including US GAAP, US Tax Account, and International Reporting Standards (IFRS).

Description: Forward looking insurers are reimagining their businesses with key strategic aims around how they engage with their customers and how they make and implement decisions. Industry experts will present a maturity framework for assessing your progress with specific case studies for how to advance in the areas of Management Information, New Business, and Inforce Management.

Description: The session is based on an article of the same name featured in the January, 2023 issue of Health Watch. It gives a step-by-step method of how to apply the average paid PMPM method to calculate IBNR with zero run-out, as opposed to current methods, which generally require a three-month run-out period. Methods for obtaining confidence intervals for the IBNR estimates will also be discussed.

Description: Explore the role of inflation across health products, including medical plans, disability, and long-term care. Explore various drivers of cost trends, wage increase, and cost of care. Understand their role in the pricing and valuation of a product and how to manage the risk.